The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Morphic Holding, Inc(NASDAQ:MORF) 
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a47-specific integrin inhibitor affec...
Website: http://www.morphictx.com
Founded: 2014
IPO Price: $15 (Jun 27, 2019)
Full Time Employees: 87
CEO: Praveen P. Tipirneni
Sector: Healthcare
Industry: Biotechnology
Morphic Holding Days Payable Outstanding ttm (DPO)
Morphic Holding Days Receivable Outstanding ttm (DSO)
Morphic Holding Op Cashflow Per Share ttm
Morphic Holding Free Cashflow Per Share ttm
Morphic Holding Cash Per Share ttm
Morphic Holding P/S ratio ttm
Morphic Holding (GAAP) P/E ratio ttm
Morphic Holding P/B ratio ttm
No extra charts and metrics for this ticker.